Human Ceruloplasmin (CP) ELISA Kit (with Control)

$453.00

Catalog Number: EC4201-7

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Catalog Number. EC4201-7 Categories: , , Tags: , , , , , Brand:

Additional information

Format

Sandwich ELISA

Entrez Gene

1356

Components

Biotinylated Human Ceruloplasmin Antibody, Chromogen Substrate (1x), Human Ceruloplasmin Microplate, Human Ceruloplasmin Standard, MIX Diluent Concentrate (10x), Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

104 pg/ml

Range

0.156 – 10 ng/ml

Samples Type

CSF, Milk, Plasma, Saliva, Serum, Urine

Associated Disease

Blood Disorder, Cardiovascular

Species

Human

UniProt

P00450

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (40 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

* Urrego-Callejas T et al. (2021) Urinary levels of ceruloplasmin and monocyte chemoattractant protein-1 correlate with extra-capillary proliferation and chronic damage in patients with lupus nephritis. Clin Rheumatol. 40(5):1853-1859

* Cody EM et al. (2021) Successful Urine Multiplex Bead Assay to Measure Lupus Nephritis Activity. Kidney Int Rep. 6(7):1949-1960.

* Wasiak S et al. (2020) Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response In Vitro, in Mice and in Patients with Cardiovascular Disease. Cardiovasc Ther. 2020:9397109

* Urrego T et al. (2020) Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis. Reumatol Clin (Engl Ed). 16(1):17-23.

* Lisowska-Myjak B et al. (2020) Can aminopeptidase N determined in the meconium be a candidate for biomarker of fetal intrauterine environment? Exp Mol Pathol. 115:104446.

* Al-Aziz AMA et al. (2020) Assessment of Ceruloplasmin, Hemopexin, and Haptoglobin in Asthmatic Children. Maced J Med Sci. 8 (B): 31-37.

* Lee DH et al. (2019) Identification of serum biomarkers for premature ovarian failure.Biochim Biophys Acta Proteins Proteom. 1867(3):219-226.

* Frankovsk I (2019) Clinical and laboratory assemment of clinical features duration, treatment and prevention of generalized paradontitis of initial and stage in pregnant women on soil of deficiency anemia of light -medium degree. National Medical University, dissertation for a scientific degree Candidate of Medical Sciences.

* Becker C et al. (2019) New approaches in diagnosis and therapy of uro-oncological diseases. Urologe A. 58(2):181-196.

* Zimpfer A et al (2018) SCIENTIFIC PROGRAM Urological Symposium. Endocrinology and Metabolism. Molecular Therapy Strategies of Bone Metastasis 19: 30-23

* Tisato V et al. (2018) TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative StressVolume 2018, Article ID 9629537, 8 pages

* Smith EMD et al. (2017) International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Pediatr Nephrol. 32(2):283-295.

* Skarzynska E et al. (2017) Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium. J Trace Elem Med Biol. 43:58-62.

* Ray S et al. (2017) Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria. Sci Rep. 6:24557.

* Gulati G et al. (2017) Prospective validation of a novel renal activity index of lupus nephritis. Lupus. 26(9):927-936.

* El-Gharabawy RM et al. (2017) Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis. Biomed Pharmacother. 85:141-147.

* Brunner HI et al. (2017) Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults. J Rheumatol. 44(8): 1239-1248.

* Brunner HI et al. (2016) Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults. Arthritis Care Res (Hoboken). 68(7):1003-11.

* Avdoshina OM et al. (2016) Formation of antioxidant protection in quails. Success. Modern. Sci. 5(9):158-162.

* Sharma S (2015) Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics. 15(2-3):394-407

* Ray S et al. (2015) Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J Proteomics. 127:103-113

* Mistry HD et al. (2015) Association between maternal micronutrient status, oxidative stress, and common genetic variants in antioxidant enzymes at 15 weeks? gestation in nulliparous women who subsequently develop preeclampsia. Free Radical Biology and Medicine. 78(2015):147-155

* Yokoyama T et al. (2014) Comparative analysis of serum proteins in relation to rheumatoid arthritis and chronic periodontitis. J Periodontol. 85(1):103-12

* Garcinuno B et al. (2014) Amperometric immunosensor for the determination of ceruloplasmin in human serum and urine based on covalent binding to carbon nanotubes-modified screen-printed electrodes. Talanta 118:61-67

* Bicer EM (2014) Compositional characterisation of human respiratory tract lining fluids for the design of disease specific simulants. King's College London.

* Ojeda I et al. (2013) Electrochemical Magnetic Immunosensors for the Determination of Ceruloplasmin. Electroanalysis. 25(9):2166-2174

* Lv M et al. (2013) Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation. PLoS One 8(3):e58735

* Cremonini E (2013) In vivo and in vitro data supporting the involvement of oxidative stress in aging-related and metabolic diseases.

* Choi GS et al. (2013) Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD. Clin Exp Allergy. 43(7):730-40.

* Joo JY and Lim HB (2012) LA-ICP-MS with microarray chip sampling to determine holoceruloplasmin in serum. J. Anal. At. Spectrom. Issue 27:1069-1073

* Craig-Schapiro R (2012) Identification of Novel Fluid Biomarkers for Alzheimer's Disease. Washington University in St. Louis.

* Brunner HI et al. (2012) Non-invasive renal protein biomarkers are associated with histological features of lupus nephritis. Arthritis Rheum. 64(8): 2687-2697.

* Brunner H et al. (2012) Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum. 64(8):2687-97.

* Zhi W et al. (2011) Selected reaction monitoring (SRM) mass spectrometry without isotope labeling can be used for rapid protein quantification. Rapid Communications in Mass Spectrometry 25(11): 1583?1588

* Wright CA et al. (2011) Label-free Quantitative Proteomics Reveals Differentially Regulated Proteins Influencing Urolithiasis. Mol Cell Proteomics. 10(8):M110.005686

* Perrin RJ et al. (2011) Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease. PloSOne Jan 12; 6(1):e16032

* Kim OY et al. (2011) Plasma ceruloplasmin as a biomarker for obesity: A proteomic approach. Clin Biochem. 44(5-6):351-356

* Comabella M et al. (2010) Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis. Brain 133:1082-1093

Loading data...